Tinasas, Cyford .

HRN: 29-23-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
CEFTRIAXONE 1G (VIAL)
07/03/2026
07/09/2026
IV
780mg
OD
Severe Infection W/ Cholestatic Hepatitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: